A Study of REGEND003 on Patients With Type 2 Diabetes Mellitus (T2DM) and Chronic Kidney Disease (CKD)

NCT07275788 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

15

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes Mellitus (T2DM) and Chronic Kidney Disease (CKD)

Interventions

BIOLOGICAL: REGEND003
OTHER: Placebo

Sponsor

Regend Therapeutics

Collaborators

[object Object]